Featured News

GE Ventures has signed an agreement to sell a portfolio of up to sixteen healthcare venture equity investments to an affiliate of Leerink Revelation Partners (“Revelation Partners”), a San Francisco-based investment firm focused on the healthcare sector.

07.01.19

Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive immune system to develop personalized diagnostics and therapeutics to improve patient lives...

Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies, announced today the closing of an oversubscribed $65 million equity financing and the hiring of Derrick Sung, Ph.D. as its Chief Financial Officer.

05.01.19

TransMedics Announces Pricing of Upsized Initial Public Offering

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, (“TransMedics”) today announced the pricing of its upsized initial public offering....

01.30.19

Beckman Coulter Life Sciences Acquires Labcyte To Expand Laboratory Automation Business

Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology...

01.04.19

Adaptive Biotechnologies to Enter Into Worldwide Collaboration and License Agreement with Genentech

Adaptive Biotechnologies, an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel...